{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:48:19Z","timestamp":1762876099964,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cjca.2019.07.636","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T19:12:51Z","timestamp":1567105971000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiovascular Events Recurrence and Coronary Artery Disease in HIV Patients: The Price We Have to Pay for the Chronicization of the Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Chiara","family":"Bernelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Battista","family":"Danzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Cerrato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Pierini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio Giovanni","family":"Ornaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Botta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guglielmo Marco","family":"Migliorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Squillace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.07.636_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.amjcard.2015.10.030","article-title":"Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013","volume":"117","author":"Feinstein","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.07.636_bib2","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/S2352-3018(18)30043-2","article-title":"Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study","volume":"5","author":"Ryom","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cjca.2019.07.636_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1357-2725(01)00024-3","article-title":"Interactions between endothelial cells and HIV-1","volume":"33","author":"Bussolino","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cjca.2019.07.636_bib4","first-page":"238","article-title":"Mechanisms of cardiovascular disease in the setting of HIV infection","volume":"35","author":"Hsue","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.07.636_bib5","first-page":"249","article-title":"Lipid abnormalities in persons living with HIV infection","volume":"35","author":"Waters","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.07.636_bib6","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/hrt.2009.177774","article-title":"HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies","volume":"95","author":"Hulten","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2019.07.636_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.atherosclerosis.2015.03.019","article-title":"High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis","volume":"240","author":"D\u2019Ascenzo","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2019.07.636_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcmg.2013.08.019","article-title":"Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?","volume":"7","author":"Stein","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2019.07.636_bib9","first-page":"e98","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association","volume":"9","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.07.636_bib10","first-page":"270","article-title":"Coronary artery disease manifestations in HIV: what, how, and why","volume":"35","author":"Sinha","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.07.636_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2012.06.063","article-title":"HIV and coronary heart disease: time for a better understanding","volume":"61","author":"Boccara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.07.636_bib12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.07.636_bib13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/cid\/civ014","article-title":"Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care","volume":"60","author":"Klein","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2019.07.636_bib14","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/S2352-3018(15)00077-6","article-title":"Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study","volume":"2","author":"Rasmussen","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cjca.2019.07.636_bib15","first-page":"326","article-title":"Getting to the heart of the matter: a review of drug interactions between HIV antiretrovirals and cardiology medications","volume":"35","author":"Gigu\u00e8re","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.07.636_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.carpath.2007.07.002","article-title":"Atherosclerotic oxalosis in coronary arteries","volume":"17","author":"Fishbein","year":"2008","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cjca.2019.07.636_bib17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0140-6736(92)92270-P","article-title":"Coronary lesions in young HIV-positive subjects at necropsy","volume":"340","author":"Tabib","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2019.07.636_bib18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.4244\/EIJ-D-15-00409","article-title":"Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention","volume":"12","author":"Theodoropoulos","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cjca.2019.07.636_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000511","article-title":"Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome","volume":"3","author":"O'Dwyer","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.cjca.2019.07.636_bib20","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1093\/eurheartj\/ehv734","article-title":"Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis","volume":"37","author":"Gili","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.07.636_bib21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.thromres.2014.05.037","article-title":"Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States","volume":"134","author":"D\u2019Ascenzo","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2019.07.636_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amjcard.2009.03.036","article-title":"Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection","volume":"104","author":"Ren","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.07.636_bib23","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/CIRCULATIONAHA.113.001874","article-title":"Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database","volume":"127","author":"Lorgis","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.07.636_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/hrt.2005.068445","article-title":"Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis","volume":"92","author":"Boccara","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2019.07.636_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/157016208783571900","article-title":"Coronary artery bypass graft in HIV-infected patients: a multicenter case control study","volume":"6","author":"Boccara","year":"2008","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.cjca.2019.07.636_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12872-017-0624-0","article-title":"Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis","volume":"17","author":"Bundhun","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjca.2019.07.636_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2459\/JCM.0000000000000767","article-title":"In-hospital and long-term outcomes of HIV-positive patients undergoing PCI according to kind of stent: a meta-analysis","volume":"20","author":"Peyracchia","year":"2019","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.cjca.2019.07.636_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/joic.12433","article-title":"Coronary revascularization for acute myocardial infarction in the HIV population","volume":"30","author":"Singh","year":"2017","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.cjca.2019.07.636_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehq372","article-title":"Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1-year prognosis","volume":"32","author":"Boccara","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.07.636_bib30","first-page":"320","article-title":"Cardiac surgery in HIV patients: state of the art","volume":"35","author":"Yanagawa","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.07.636_bib31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurheartj\/ehr456","article-title":"Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy","volume":"33","author":"D\u2019Ascenzo","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.07.636_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/infdis\/jis630","article-title":"Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells","volume":"208","author":"Hatano","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cjca.2019.07.636_bib33","first-page":"1676","article-title":"Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study","volume":"38","author":"Hauguel-Moreau","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.07.636_bib34","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-M\u00f8ller","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.07.636_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/QAD.0000000000001666","article-title":"Abacavir use and risk of recurrent myocardial infarction","volume":"32","author":"Sabin","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.cjca.2019.07.636_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2018.05.001","article-title":"Evaluation of coronary features of HIV patients presenting with ACS: the CUORE, a multicenter study","volume":"274","author":"Peyracchia","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19311894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19311894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:40:45Z","timestamp":1760107245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19311894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0828282X19311894"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.07.636","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Events Recurrence and Coronary Artery Disease in HIV Patients: The Price We Have to Pay for the Chronicization of the Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.07.636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}